Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-23-024158

EVP Research & Development sold 2,500 shares at $34.86 ($87,150)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Malik Fady Ibraham EVP Research & Development 2023-09-14 Sale 10b5-1 −2,500 $34.86 $87,150 155,664 D: show line 1 in the form
Open-market sales · 2,500 sh · avg $34.86 · $87,150
Loading xslF345X05/form4.xml…